⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
STRO News
Sutro Biopharma, Inc.
Form 8-K
sec.gov
STRO
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
globenewswire.com
STRO
Sutro Biopharma to Participate in Upcoming Investor Conferences
globenewswire.com
STRO
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
globenewswire.com
STRO
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
globenewswire.com
STRO
Sutro Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
STRO
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines
prnewswire.com
GTBP
ADCT
STRO
CRNX
TCRX
Sutro Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
globenewswire.com
STRO
Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
STRO
Sutro Biopharma Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in TF-Expressing Solid Tumors
globenewswire.com
STRO